Smart Molding International 2-2024

50 smart_molding international 2/2024 materials Henkel introduced Loctite 3D MED3394, a novel solution for post-sterilization durability Following up to 25 autoclave cycles, Loctite 3D MED3394 preserves mechanical properties and dimensional stability, alongside high feature accuracy and low solvent absorption. This resin ensures reliable performance in demanding medical applications. W ith the introduction of L o c t i t e 3D MED3394 Henkel has launched a fur- ther innovation within its growing portfolio of medical-grade resins for 3D printing. The novel resin repre- sents a significant advancement, no - table for its robust resistance against sterilization methods that commonly challenge other photopolymers in the market. Following up to 25 autoclave cycles, Loctite 3D MED3394 preserves mechanical properties and dimensional stability, alongside high feature accu- racy and low solvent absorption. This resin ensures reliable performance in demanding medical applications. In addition to its sterilization resilience, Loctite 3D MED3394 is compliant with stringent ISO 10993 standards for biocompatibility, meeting the highest safety and quality requirements. Furthermore, the product is formulated without CMR (Carcinogenic, Mutagenic, or Reproductively hazardous) ingredients. Its dimensional accuracy and stability make it ideal for applications requiring sterilization or chemical resistance, including surgical tools, hospital devices, and clean room environments. Available in bothwhite and sheer black, Loctite 3DMED3394 features impressive Heat Deflection Temperature (HDT) and tensile properties, setting a new benchmark for precision and durability in medical applications. Loctite 3D MED3394 benefits: • Ability to withstand multiple methods and rounds of sterilization while maintaining performance. • Capable of meeting ISO 10993-5, -10, -11 & -23 biocompatibility standards for medical applications • USP Class VI Certified • Excellent chemical resistance • High Dimensional Accuracy • Good balance of HDT and toughness. “We are proud of this advancement in the field of medical 3D printing,” said Dr. Daniel Adams, Vice President at Henkel for Loctite 3D Printing. “With our new sterilizable material, Loctite 3D MED3394, we are addressing a clear customer need and show our dedication to providing innovative solutions that support healthcare professionals to deliver quality patient care.” The Loctite 3D Printing team was showcasing Loctite 3D MED3394 at Rapid+TCT 2024 (June 25-27, 2024), providing attendees with the opportunity to experience its performance and versatility firsthand. About Henkel With its brands, innovations and technologies, Henkel holds leadingmarket positions worldwide in the industrial and consumer businesses. The business unit Adhesive Technologies is the global leader in the market of adhesives, sealants and functional coatings. The company's three strongest brands are Loctite, Persil and Schwarzkopf. Henkel’s preferred shares are listed in the German stock index DAX. Sustainability has a long tradition at Henkel, and the company has a clear sustainability strategy with concrete targets. Henkel was founded in 1876 and today employs a diverse team of more than 50,000 peopleworldwide – united by a strong corporate culture, shared values and a common purpose: “Pioneers at heart for the good of generations.” Henkel www.henkel.com Henkel has introduced Loctite 3D MED3394, a novel solution for post-sterilization durability (picture: Henkel)